Get the Stockscreener App
120.53
1.21%
-1.44
Illumina Inc stock is traded at $120.53, with a volume of 1.31M.
It is down -1.21% in the last 24 hours and up +26.23% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$121.97
Open:
$121.64
24h Volume:
1.31M
Relative Volume:
0.78
Market Cap:
$4.97B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
15.27
EPS:
7.8957
Net Cash Flow:
$943.00M
1W Performance:
-1.21%
1M Performance:
+26.23%
6M Performance:
+45.27%
1Y Performance:
-10.74%
1-Day Range:
$119.85
$122.38
1-Week Range:
$117.10
$123.65
52-Week Range:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
120.53 | 18.64B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
574.05 | 216.42B | 43.74B | 6.58B | 6.11B | 17.31 |
|
A
Agilent Technologies Inc
|
145.11 | 40.78B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
DHR
Danaher Corp
|
221.84 | 159.29B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
MTD
Mettler Toledo International Inc
|
1,408.79 | 28.53B | 3.87B | 829.75M | 847.84M | 39.48 |
|
WAT
Waters Corp
|
377.15 | 22.42B | 2.91B | 622.64M | 620.14M | 10.48 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
Transcript : Illumina, Inc. Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-19-2025 09 - MarketScreener
Illumina at Wolfe Research Conference: Strategic Growth Amid Challenges - Investing.com India
Illumina at Wolfe Research Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Will Illumina Inc. (ILU) stock justify high valuationQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Why analysts maintain buy rating on Illumina Inc. (ILU) stockTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
Published on: 2025-11-19 04:40:33 - newser.com
Will Illumina Inc. (ILU) stock keep high P E multiplesWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Is Illumina Inc. (ILU) stock positioned for digital growth eraPortfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-11-18 23:37:24 - newser.com
Is Illumina Inc. (ILU) stock inflation resilientJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Illumina sells GRAIL shares worth $79.85 million - Investing.com
Tackling antimicrobial resistance, one genome at a time - Illumina
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
The Bull Case For Illumina (ILMN) Could Change Following Export Ban Easing in China—Learn Why - simplywall.st
Why Illumina Inc. stock is considered a top pickInsider Selling & Intraday High Probability Alerts - newser.com
Why The Narrative Around Illumina Is Shifting After Recent Analyst Upgrades and Sector Changes - Yahoo Finance
Is Illumina Inc. forming a bottoming baseWeekly Stock Report & Low Volatility Stock Recommendations - newser.com
Why Illumina Inc. (ILU) stock benefits from AI revolution2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
What moving averages say about Illumina Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Is Illumina Inc. stock a buy in volatile marketsIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Technical analysis overview for Illumina Inc. stockMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Strategies to average down on Illumina Inc.July 2025 Review & Reliable Momentum Entry Alerts - newser.com
Analyzing Illumina Inc. with risk reward ratio charts2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Illumina Inc Stock Analysis and ForecastVolatility Trading Techniques & Fast Profit Stock Ideas - earlytimes.in
Real time pattern detection on Illumina Inc. stockQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Is Illumina Inc. (ILU) stock a buy on weaknessPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Will Illumina Inc. stock benefit from automationJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
Illumina’s Market Dominance Faces New Test As Roche Plans 2026 Sequencer Launch - Citeline News & Insights
Published on: 2025-11-13 22:27:47 - newser.com
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):